Author:
Hamid Nazim Faisal,Albalawi Nader Mousa Rubayyi,Alanazi Fawaz Khalifah M,Alharbi Faisal Mohammed,Aljabri Moath Omar
Subject
Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Drug Discovery
Reference35 articles.
1. Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312: 1033-48.
2. Huynh KQ, Gautam V, Cho BH, Jang YS, Lee VS, Tran-Van H. Molecular Dynamics Simulations Reveal Novel 12-Mer Peptide Derived From CPE30 of Clostridium Perfringens Targeting M Cell. Int. J. Pharm. Res. Allied Sci. 2020;9(4):1-10
3. Selimov MA, Nagdalian AA, Povetkin SN, Statsenko EN, Kulumbekova IR, Kulumbekov GR et al. Investigation of CdCl₂ Influence on Red Blood Cell Morphology. Int. J. Pharm. Phytopharm. Res. 2019;9(5):8-13.
4. Adebiyi MG, Manalo JM, Xia Y. Metabolomic and molecular insights into sickle cell disease and innovative therapies. Blood Adv. 2019;3(8):1347-55.
5. Strouse J. Sickle cell disease. Handb Clin Neurol 2016;138:311-24.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献